HARBIN ZHENBAO PHARMACEUTICAL CO., LTD.
Patent Applications and Registrations
Patent applications and USPTO patent grants for HARBIN ZHENBAO PHARMACEUTICAL CO., LTD..The latest application filed is for "salt serving as akt inhibitor and crystal thereof".
- HARBIN ZHENBAO PHARMACEUTICAL CO., LTD. - Heilongjiang CN
| Patent | Date |
|---|---|
| Salt serving as AKT inhibitor and crystal thereof Grant 11,261,196 - Li , et al. March 1, 2 | 2022-03-01 |
| Salt form and crystal form serving as FGFR and VEGFR inhibitor compounds, and preparation method therefor Grant 11,078,194 - Chen , et al. August 3, 2 | 2021-08-03 |
| Salt Serving As Akt Inhibitor And Crystal Thereof App 20210087205 - LI; Gang ; et al. | 2021-03-25 |
| Salt Form And Crystal Form Serving As Fgfr And Vegfr Inhibitor Compounds, And Preparation Method Therefor App 20200361913 - CHEN; Zhengxia ; et al. | 2020-11-19 |
| Dihydropyrazole azepine compound serving as Akt inhibitor Grant 10,654,868 - Lu , et al. | 2020-05-19 |
| Vinyl compounds as FGFR and VEGFR inhibitors Grant 10,519,133 - Chen , et al. Dec | 2019-12-31 |
| Vinyl Compounds As Fgfr And Vegfr Inhibitors App 20180222886 - CHEN; Shuhui ; et al. | 2018-08-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 